October 11, 2024
In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses how orforglipron, the second oral GLP-1 agonist for weight loss, stacks up against oral semaglutide in terms of dosing, efficacy, safety, and more
FAQs Q: Is this really safe compared to prescription weight loss meds
For lean individuals, particularly those with muscular thighs from training, the margin between subcutaneous and intramuscular injection narrows
How does GHK-CU dosing compare to BPC-157 or TB-500
Protective properties of 6-gingerol-rich fraction from Zingiber officinale (Ginger) on chlorpyrifos-induced oxidative damage and inflammation in the brain, ovary and uterus of rats